The new center, launched with a $20 million gift from the David Koch Jr. Foundation, aims to advance research, education, and care for patients with glomerular kidney disease.
Many Black Americans thought to have a high risk of developing kidney disease possess a genetic variant that eradicates the extra risk, a new study from Columbia researchers has found.
By analyzing thousands of genetic risk variants, a new algorithm developed by Columbia researchers may be able to predict your risk of developing chronic kidney disease decades before onset.
Kidney transplant recipients and those waiting for a transplant face a high risk of dying from COVID, with patients from racial and ethnic minorities at greater risk.
DNA sequencing can be used to identify the underlying genetic cause of many rare types of chronic kidney disease, leading to better treatment, finds a new study from Columbia University.
A biopsy test that helps transplant centers select kidneys for transplantation is often inaccurate, a new study has found, suggesting that reliance on the biopsy should be reduced.